SCHEMBL17625290

SCHEMBL17625290

CC(C)(C)OC1CCN(Cl)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1106464 0.78 HRH3 (0.37) —
SCHEMBL9611082 0.76 ATM (0.32) —
SCHEMBL21933618 0.76 — —
SCHEMBL10202604 0.76 — —
SCHEMBL22959617 0.76 — —
SCHEMBL16814052 0.75 ATM (0.30) —
SCHEMBL1106443 0.74 SIGMAR1 (0.32) —
SCHEMBL12395683 0.73 HRH3 (0.41) —
SCHEMBL1106458 0.73 HRH3 (0.40) —
SCHEMBL25143813 0.71 POLB (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9790235-B2 MK2 inhibitors and uses thereof CELGENE CAR LLC (BM) 2017-10-17 — — US disclosed
US-20170114073-A1 MK2 INHIBITORS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY 2017-04-27 — — US disclosed
US-9458175-B2 MK2 inhibitors and uses thereof CELGENE AVILOMICS RESEARCH, INC. (US) 2016-10-04 — — US disclosed
WO-2016044463-A2 MK2 INHIBITORS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2016-03-24 — — WO disclosed
Send feedback